The share price is continuously declining and board has completely failed. It is better to sell the company to some market leader like A2M at good deal, if board really cares for share holders and really want them to give potential relief. I still think share price will bounce back to 25c-30c range and selling it now may fetch some good return. I can only see the savage in selling the company in good solid hands.
- Forums
- ASX - By Stock
- Ann: Trading Update
The share price is continuously declining and board has...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $120.5M |
Open | High | Low | Value | Volume |
13.0¢ | 13.5¢ | 13.0¢ | $65.41K | 489.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 1077846 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 164257 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 1077846 | 0.130 |
28 | 1601152 | 0.125 |
53 | 2564828 | 0.120 |
40 | 2053195 | 0.115 |
36 | 753223 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 164257 | 4 |
0.140 | 1045320 | 16 |
0.145 | 1157400 | 15 |
0.150 | 1761148 | 32 |
0.155 | 820549 | 20 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
BUB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online